Eco-guided Neuromodulation of the Femoral Nerve on the Performance of Amateur Athletes.
17 de julio de 2026 actualizado por: Jacobo Rodríguez Sanz, Universitat Internacional de Catalunya
Effectiveness of Eco-guided Neuromodulation of the Femoral Nerve on the Performance of Amateur Athletes. Randomized Controlled Crossover Clinical Trial
This randomized crossover study aims to evaluate whether different percutaneous electrical nerve stimulation (PENS) protocols produce changes in neuromuscular performance in healthy adults.
PENS involves the ultrasound-guided application of an electrical current through a needle to modulate motor neuron excitability.
Each participant will undergo five intervention sessions: (1) a long-term potentiation (LTP)-based protocol with impulse trains, (2) a 10 Hz protocol with 10 s stimulation and 10 s rest repeated ten times, (3) a 5-55 protocol with 100 Hz stimulation for 5 s followed by 55 s rest repeated five times, (4) a high-intensity burst (HIB) protocol applied at a high current intensity close to 1000 mA and repeated three times, and (5) a placebo condition.
All interventions will be applied bilaterally by an experienced physiotherapist under ultrasound guidance, with a two-week washout between sessions.
The objective of this trial is to assess whether these stimulation patterns produce measurable changes in squat execution velocity, jump performance, and quadriceps strength.
The findings may help identify the most effective stimulation strategy for enhancing neuromuscular performance.
Descripción general del estudio
Estado
Reclutamiento
Condiciones
Tipo de estudio
Intervencionista
Inscripción (Estimado)
23
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Estudio Contacto
- Nombre: Jacobo Rodríguez Sanz, PhD
- Número de teléfono: +34 636-136-789
- Correo electrónico: jrodriguezs@uic.es
Ubicaciones de estudio
-
-
Barcelona
-
Sant Cugat del Vallès, Barcelona, España, 08195
- Reclutamiento
- Universitat Internacional de Catalunya
-
Contacto:
- Jacobo Rodríguez Sanz, PhD
- Número de teléfono: +34 636 136 789
- Correo electrónico: jrodriguezs@uic.es
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
Acepta Voluntarios Saludables
Sí
Descripción
Inclusion Criteria:
- Athletes aged between 18 and 30 years.
- Familiarized with performing barbell back squats using an Olympic bar.
- Engaged in regular training at least three times per week during the last six months.
- Able to perform squat and jump tests safely.
- Provided written informed consent to participate in the study.
Exclusion Criteria:
- Sports injury within the last two months or current inability to perform physical activity.
- Inability to understand or follow the instructions provided by the therapist.
- Participation in another research study during the same period.
- Belonephobia (fear of needles).
- Ongoing medical or pharmacological treatment that could interfere with neuromuscular performance (e.g., anticonvulsants, antidepressants, or similar medications).
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación cruzada
- Enmascaramiento: Doble
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Theta Burst Protocol
The intervention consists of the bilateral, ultrasound-guided insertion of a needle for percutaneous electrical nerve stimulation (PENS), following a theta-burst pattern designed to produce long-term potentiation-like effects.
An asymmetric biphasic compensated current with a rectangular positive phase and a triangular negative phase is applied at a frequency of 100 Hz for 5 seconds, followed by 55 seconds of rest, repeated five times.
The pulse width is 240 µs, and the intensity is maintained above the motor threshold and below the pain threshold.
|
The intervention consists of the bilateral, ultrasound-guided insertion of a needle for percutaneous electrical nerve stimulation (PENS), following a theta-burst pattern designed to produce long-term potentiation-like effects.
An asymmetric biphasic compensated current with a rectangular positive phase and a triangular negative phase is applied at a frequency of 100 Hz for 5 seconds, followed by 55 seconds of rest, repeated five times.
The pulse width is 240 µs, and the intensity is maintained above the motor threshold and below the pain threshold.
Otros nombres:
|
|
Experimental: 10-10-10 Protocol
The intervention consists of the bilateral, ultrasound-guided insertion of a needle for percutaneous electrical nerve stimulation (PENS).
An asymmetric biphasic compensated current is applied, with a rectangular positive phase and a triangular negative phase, at a frequency of 10 Hz, pulse width of 240 µs, and an intensity above the motor threshold and below the pain threshold.
Each stimulation period lasts 10 seconds, followed by 10 seconds of rest, repeated ten times.
|
Percutaneous electrical nerve stimulation (PENS) applied under ultrasound guidance at 10 Hz, consisting of 10 seconds of stimulation followed by 10 seconds of rest, repeated ten times.
The current intensity is adjusted to produce visible muscle contraction without pain.
|
|
Experimental: 5-55 Protocol
Ultrasound-guided PENS protocol applying a 100 Hz stimulation for 5 s followed by 55 s of rest, repeated five times.
The intensity is adjusted to a tolerable tingling sensation, below the pain threshold.
|
Percutaneous electrical nerve stimulation (PENS) applied under ultrasound guidance at 100 Hz for 5 seconds, followed by 55 seconds of rest, repeated five times.
The current intensity is adjusted to elicit a mild tingling sensation while remaining below the pain threshold.
|
|
Experimental: HIB Protocol (High-Intensity Burst)
Ultrasound-guided PENS protocol consisting of high-intensity bursts applied bilaterally at a current intensity close to 1000 mA, repeated three times.
The intensity is set individually, approaching but not exceeding the participant's tolerance threshold.
|
Percutaneous electrical nerve stimulation (PENS) applied under ultrasound guidance using high-intensity bursts delivered bilaterally at a current intensity close to 1000 mA, repeated three times.
The stimulation intensity is individually adjusted to approach but not exceed the participant's tolerance threshold.
Otros nombres:
|
|
Comparador falso: Placebo
Ultrasound-guided needle insertion at the same anatomical location without electrical stimulation.
The device is manipulated to simulate treatment, but no current is delivered.
|
A sham PENS procedure involving ultrasound-guided needle insertion at the same anatomical site without electrical stimulation.
The device is manipulated to simulate treatment, but no current is delivered.
Participants are informed they might not feel any sensation during the session.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Periodo de tiempo |
|---|---|
|
Changes in squat execution velocity (m/s) measured with a linear encoder
Periodo de tiempo: pre-intervention, immediately after the intervention
|
pre-intervention, immediately after the intervention
|
Medidas de resultado secundarias
Medida de resultado |
Periodo de tiempo |
|---|---|
|
Changes in vertical jump performance (jump height) measured with the MyJump2 app.
Periodo de tiempo: pre-intervention, immediately after the intervention
|
pre-intervention, immediately after the intervention
|
|
Changes in quadriceps strength measured in newtons using a force gauge
Periodo de tiempo: pre-intervention, immediately after the intervention
|
pre-intervention, immediately after the intervention
|
|
Changes in muscle activation in microvolts (μV) measured via surface electromyography
Periodo de tiempo: pre-intervention, immediately after the intervention
|
pre-intervention, immediately after the intervention
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Estimado)
1 de septiembre de 2026
Finalización primaria (Estimado)
30 de septiembre de 2026
Finalización del estudio (Estimado)
30 de septiembre de 2026
Fechas de registro del estudio
Enviado por primera vez
13 de julio de 2026
Primero enviado que cumplió con los criterios de control de calidad
17 de julio de 2026
Publicado por primera vez (Actual)
22 de julio de 2026
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
22 de julio de 2026
Última actualización enviada que cumplió con los criterios de control de calidad
17 de julio de 2026
Última verificación
1 de julio de 2026
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- CBAS-2023-19
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .